The Defense Production Act (DPA) and COVID-19: Key Authorities and Policy Considerations

reportActive / Technical Report | Accesssion Number: AD1169964 | Open PDF

Abstract:

As the coronavirus (COVID-19) pandemic evolves, the United States faces drug and medical supply scarcities due to disrupted supply chains and increased demand. In response, the President may exercise emergency authorities under the Defense Production Act of 1950 (DPA; 50 U.S.C. sections 4501 et seq.) to address supply shortages and economic development impacts. During a press conference on March 18, 2020, the President indicated that he would invoke the DPA to address domestic essential goods and materials shortages caused by the pandemic. This Insight considers the various DPA authorities that maybe used going forward and explores potential policy considerations for Congress.

Author(s):
Cecire, Michael H. ; Peters, Heidi M.
Author Organization(s):
LIBRARY OF CONGRESS WASHINGTON DC
Funding Organization(s):
LIBRARY OF CONGRESS CONGRESSIONAL RESEARCH SERVICE, WASHINGTON , DC
Document Type:
Technical Report/Congressional Report
Publication Date:
2020 Mar 18
Pagination:
4

Security Markings

DOCUMENT & CONTEXTUAL SUMMARY

Distribution Code:
A - Approved For Public Release
Distribution Statement: Public Release

RECORD

Collection: TRECMS
Subject Terms
Communities of Interest:
No COI(s) Identified
Descriptor(s):
national security, covid-19, congress, homeland security, department of defense, department of homeland security, public health, security, united states government, emergencies, supply chain, economic development, governments, united states, acquisition, domestic, government procurement
Keyword(s):
defense production act
Subject Categories:
Behavioral and Social Sciences
Creation Date:
2022 May 27
Update Date:
2022 Jul 08